DarioHealth Corp. DRIO Archives - Page 3 of 5

TuesdayOct 13, 2020 11:19 am

QualityStocksNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Platform Selected for Integration in Vitality’s Gateway Flex

DarioHealth (NASDAQ: DRIO), a pioneer in the global digital-therapeutics market, today announced that Vitality Group has chosen the company's digital therapeutics solutions for inclusion in Vitality's new Gateway Flex offering. According to the update, Gateway Flex enables employers to personalize the health-care experience to meet the diverse and rapidly changing needs of their employees and allows employers to pay only for solutions in which their employees engage. “We believe that our inclusion in Vitality's Gateway Flex offering represents another recent validation of our digital therapeutic solution and reinforces our position as a partner of choice,” Rick Anderson, president and general…

MondaySep 21, 2020 2:11 pm

QualityStocksNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) and HMC HealthWorks Enter Sales and Distribution Partnership

DarioHealth (NASDAQ: DRIO), a pioneer in the global digital-therapeutics market, together with HMC HealthWorks, a 40-year veteran in health-care management with clinically-integrated models of care that reduce health-care costs and improve population health, today announced entry into a sales and distribution agreement. Under the partnership, HMC will incorporate DarioHealth's digital therapeutics solution into its care management programs on a stand-alone basis as well as for incorporation within HMC’s comprehensive solutions. "We believe that this agreement with HMC is further validation of the progress we have made in transitioning to a leading provider of digital-therapeutics solutions to payors, employers and other…

WednesdaySep 16, 2020 11:37 am

QualityStocksNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Announces Strategic Scientific Advisory Board Appointment

DarioHealth (NASDAQ: DRIO), a pioneer in the global digital-therapeutics market, today announced that Eric Milledge has joined DarioHealth as chairman of the company's newly-established Scientific Advisory Board (“SAB”). Milledge has dedicated his entire career to the field of health care, with a focus on pharmaceuticals and medical devices, and spent 34 years at Johnson & Johnson, building a vast network of relationships across the health-care landscape. "We are very pleased that Eric is spearheading our effort to assemble a world-class SAB," said Dario's CEO Erez Raphael in the press release. "He brings significant experience and knowledge relevant to our industry,…

WednesdaySep 02, 2020 2:25 pm

QualityStocksNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) CEO Discusses Transformation to B2B2C Digital Therapeutics

DarioHealth (NASDAQ: DRIO), a global digital-therapeutics company serving its users with dynamic mobile-health solutions, has recently achieved a series of successes and anticipates even more in the coming weeks. Among drivers of DRIO’s path toward leading cutting-edge solutions is the global pandemic, which has unveiled dynamics of the company’s business model that provide distinction in an era in need of next-generation health care. A recent article discussing this includes commentary from DarioHealth’s CEO Erez Raphael, who stated, “The COVID-19 pandemic has accelerated our ongoing transformation to a business-to-business-to-consumer (‘B2B2C’) digital therapeutics leader. We advanced late-stage discussions with health plans and…

WednesdayAug 26, 2020 2:11 pm

QualityStocksNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Positioned to Compete in ‘Largely Untapped US Market’

DarioHealth (NASDAQ: DRIO), a global digital-therapeutics company serving its users with dynamic mobile-health solutions, recently completed a round of successful fundraising that will assist in expanding the availability of its platform. DarioHealth secured approximately $28.6 million in aggregate gross proceeds from health-care funds and institutions across the United States and Israel through the private-placement transaction with accredited investors. The new capital coupled with existing cash puts the company in its best financial state since its inception (http://ibn.fm/uKWvc). A recent article discussing this quotes Dario CEO Erez Raphael, who stated, “We are pleased to have the confidence of our largest shareholder and…

WednesdayAug 19, 2020 12:36 pm

QualityStocksNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Taking Health Care Home Through Innovative Platform

DarioHealth (NASDAQ: DRIO), a global digital-therapeutics company serving its users with dynamic mobile-health solutions, is a clear point-of-need innovator in today’s standoffish environment. The company supplies hospitals with next-generation technology to provide patients necessary care as they are “roomed” at home under a remote-monitoring regimen. A recent article discussing this reads, “DarioHealth’s Remote Patient Monitoring (‘RPM’) digital therapeutics platform provides physicians with essential information and also delivers occasional ‘nudges’ to patients when its automated programming recognizes a need (http://ibn.fm/tC5si).” To view the full article, visit http://ibn.fm/sY6wD About DarioHealth Corp. DarioHealth is a leading, global, digital-therapeutics company revolutionizing the way people with…

WednesdayAug 19, 2020 10:40 am

QualityStocksNewsBreaks – Shares of DarioHealth Corp. (NASDAQ: DRIO) Reach 52-Week High

Shares of DarioHealth Corp. (NASDAQ: DRIO), a pioneer in the global digital therapeutics market, reached a new 52-week high on Wednesday. In morning trading, the company’s shares reached a peak of $22.49 on volume of over 170,000, up from an opening price of $18.75. At time of publishing, shares of DRIO hover around $21.35, marking a PPS increase of roughly 13.87% on the day. About DarioHealth Corp. DarioHealth Corp. is a leading, global digital therapeutics company revolutionizing the way people with chronic conditions manage their health. By delivering evidence-based interventions that are driven by data, high-quality software and coaching, the…

TuesdayAug 18, 2020 11:33 am

DarioHealth Corp. (NASDAQ: DRIO) Beats Street Q2 Revenue Estimates by 20% and Reveals Late Stage, Virtual Healthcare, B2B2C Sales Pipeline

DarioHealth Corp. reported its second quarter financial results Aug. 12, showing a revenue increase on a quarter-to-quarter basis, as well as gross profit increases of 95 percent and 60 percent on year-over-year quarterly and six-month measures, respectively CEO Erez Raphael recently appeared on Fox Business news forum “The Claman Countdown” to discuss the company’s health and the state of the telemedicine industry amid reports of high-value M&A activity Telemedicine has gained significant popularity as a means of maintaining health standards while reducing or eliminating the risk of virus transmission during the ongoing COVID-19 pandemic U.S. President Donald Trump recently signed…

MondayAug 17, 2020 2:05 pm

QualityStocksNewsBreaks – Aegis Capital Corp. Initiates Coverage, Issues ‘Buy’ Rating on DarioHealth Corp. (NASDAQ: DRIO)

Aegis Capital Corp. has initiated coverage with a ‘Buy’ rating and price target of $25 on shares of DarioHealth’s (NASDAQ: DRIO) stock. DRIO is a pioneer in the global digital therapeutics (“DTx”) industry with its popular, smartphone-centered personalized chronic illness management software-as-a-service (SaaS). The report reads, “We initiate coverage on DRIO with a BUY rating and $25 PT based on a 5.6x EV/Sales multiple applied to FY:21E sales of $11.4mm, a discount to the est. peer average of 8.1x. We believe this multiple is warranted thanks to the growth prospects and quality of the product offering, underpinned by published efficacy…

WednesdayAug 12, 2020 10:28 am

QualityStocksNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Announces Q2 Revenue, Overview of Key Company Highlights and Development

DarioHealth (NASDAQ: DRIO), a pioneer in the global digital therapeutics market, has released a business update, including financial numbers and corporate achievements for the second quarter ended June 30, 2020. Highlights of the report include the company’s announcement of two Remote Patient Monitoring (“RPM”) agreements in the United States as well as an agreement with Williams Medical, which allowed Dario to enter the United Kingdom. In addition, the company reported Q2 revenues of $1.79 million, a 7.2% sequential increase from Q1 2020. "The COVID-19 pandemic has accelerated our ongoing transformation to a business-to-business-to-consumer (B2B2C) digital therapeutics leader," said Dario CEO Erez…

Site Search

Company Search

Tag: DarioHealth Corp. DRIO